Inhaled glucocorticoids: new developments relevant to updating of the asthma management guidelines.
Barnes
P J
PJ
Department of Thoracic Medicine, National Heart and Lung Institute, London, U.K.
D000042:Absorption; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000730:Androstadienes / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000008:administration & dosage; D019819:Budesonide; D002648:Child; D004334:Drug Administration Schedule; D000068298:Fluticasone; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D017410:Practice Guidelines as Topic; D011282:Pregnenediones / Q000008:administration & dosage; D012307:Risk Factors
D000336:Aerosols; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide; D000068298:Fluticasone; D001507:Beclomethasone